Ticker Details
Organon & Co..
IPO Date:	May 14, 2021
Sector:	Healthcare
Industry:	Drug Manufacturers - General
Market Cap:	$3.61B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.34 | 1.79%
Avg Daily Range (30 D):	$0.03 | 0.21%
Avg Daily Range (90 D):	$0.09 | 0.88%

Institutional Daily Volume
Avg Daily Volume:	2.8M
Avg Daily Volume (30 D):	2.13M
Avg Daily Volume (90 D):	5.25M

Trade Size
Avg Trade Size (Sh.):	114
Avg Trade Size (Sh.) (30 D):	190
Avg Trade Size (Sh.) (90 D):	235

Institutional Trades
Total Institutional Trades:	4,837
Avg Institutional Trade:	$3.38M
Avg Institutional Trade (30 D):	$2.62M
Avg Institutional Trade (90 D):	$2.63M
Avg Institutional Trade Volume:	.19M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$7.69M
Avg Closing Trade (30 D):	$5.05M
Avg Closing Trade (90 D):	$7M
Avg Closing Volume:	437.05K

News

Jun 22, 2026 @ 5:47 PM BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Inve... Source: Brodsky & Smith

Jun 17, 2026 @ 1:14 AM Halper Sadeh LLC is Investigating Whether LPRO, NU... Source: Halper Sadeh Llc

Jun 16, 2026 @ 7:56 PM BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Inve... Source: Brodsky & Smith

Jun 10, 2026 @ 12:04 AM Halper Sadeh LLC is Investigating Whether NUVL, SU... Source: Halper Sadeh Llc

May 22, 2026 @ 6:20 AM Hanmi Pharmaceutical se asocia con Organon para ex... Source: Na

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$.79	$.41	$.56
Diluted EPS	$.78	$.4	$.55
Revenue	$6.13B	$1.56B	$1.46B
Gross Profit	$3.23B	$847M	$783M
Net Income / Loss	$209M	$108M	$146M
Operating Income / Loss	$491M	$183M	$213M
Cost of Revenue	$2.9B	$711M	$677M
Net Cash Flow	$533M	$16M	$542M
PE Ratio